Datroway granted priority review in the US as 1st-line treatment for patients with metastatic triple-negative...

Takeda submits new drug application for Mirvetuximab Soravtansine for folate receptor alpha-positive, platinum-resistant recurrent ovarian...

Astellas submits Supplemental New Drug Application in Japan for PADCEV™ (Enfortumab vedotin) with Keytruda ®...

The supplemental application for BB-1701 for injection from Bliss Biopharmaceuticals (Hangzhou) has been accepted by...

DS3790 enters clinical development as first DXd ADC in hematology from industry-leading ADC portfolio of...

AdvanCell announces collaboration and exclusive licensing agreement with 48Hour discovery to develop a novel peptide-based...